Recurrence of primary biliary cholangitis after liver transplantation: A Japanese perspective.
作者信息
Montano-Loza Aldo J, Mason Andrew L
机构信息
Division of Gastroenterology and Liver Unit, University of Alberta Hospital, Edmonton, Canada.
出版信息
Hepatol Commun. 2017 Jul 7;1(5):391-393. doi: 10.1002/hep4.1058. eCollection 2017 Jul.
Abstract
摘要
相似文献
1
Recurrence of primary biliary cholangitis after liver transplantation: A Japanese perspective.肝移植后原发性胆汁性胆管炎的复发：日本视角
Hepatol Commun. 2017 Jul 7;1(5):391-393. doi: 10.1002/hep4.1058. eCollection 2017 Jul.
2
Recurrence of primary biliary cirrhosis, autoimmune cholangitis and primary sclerosing cholangitis after liver transplantation.肝移植后原发性胆汁性肝硬化、自身免疫性胆管炎和原发性硬化性胆管炎的复发
Clin Liver Dis. 1998 May;2(2):421-35, xi. doi: 10.1016/s1089-3261(05)70016-7.
3
Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation.肝移植后原发性硬化性胆管炎、原发性胆汁性胆管炎和自身免疫性肝炎的复发
Best Pract Res Clin Gastroenterol. 2017 Apr;31(2):187-198. doi: 10.1016/j.bpg.2017.04.004. Epub 2017 Apr 12.
4
Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation.肝移植后自身免疫性疾病、原发性硬化性胆管炎、原发性胆汁性肝硬化和自身免疫性肝炎的复发。
Liver Transpl. 2009 Nov;15 Suppl 2:S25-34. doi: 10.1002/lt.21916.
5
Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades.过去三十年来，欧洲原发性胆汁性胆管炎肝移植的趋势。
Aliment Pharmacol Ther. 2019 Feb;49(3):285-295. doi: 10.1111/apt.15060. Epub 2018 Dec 18.
6
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis.原发性胆汁性胆管炎肝移植术后预防性熊去氧胆酸治疗的长期影响。
J Hepatol. 2020 Sep;73(3):559-565. doi: 10.1016/j.jhep.2020.03.043. Epub 2020 Apr 7.
7
Frequent overlap of active hepatitis in recurrent primary sclerosing cholangitis after living-donor liver transplantation relates to its rapidly progressive course.在活体肝移植后复发性原发性硬化性胆管炎中，活动性肝炎频繁重叠与疾病的快速进展过程有关。
Hum Pathol. 2011 Sep;42(9):1329-36. doi: 10.1016/j.humpath.2010.01.029. Epub 2011 Feb 21.
8
Recurrence of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation.肝移植后自身免疫性肝炎、原发性胆汁性肝硬化和原发性硬化性胆管炎的复发
Acta Gastroenterol Belg. 2005 Jul-Sep;68(3):331-6.
9
Liver transplantation in chronic cholestatic conditions.慢性胆汁淤积性疾病的肝移植。
Front Biosci (Landmark Ed). 2012 Jan 1;17(3):959-69. doi: 10.2741/3966.
10
Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?原发性胆汁性肝硬化和原发性硬化性胆管炎的肝移植：药物治疗会改变时机和选择吗？
Liver Transpl Surg. 1998 Sep;4(5 Suppl 1):S9-17.
引用本文的文献
1
The impact of recipient and donor gender-match and mismatch on the post-liver transplant outcomes of patients with primary biliary cholangitis.受者和供者性别匹配和不匹配对原发性胆汁性胆管炎患者肝移植后结局的影响。
Dig Liver Dis. 2023 Sep;55(9):1242-1252. doi: 10.1016/j.dld.2023.03.018. Epub 2023 Apr 19.
本文引用的文献
1
Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: A Japanese multicenter retrospective study.女性患者肝移植后原发性胆汁性胆管炎复发的危险因素：一项日本多中心回顾性研究。
Hepatol Commun. 2017 May 16;1(5):394-405. doi: 10.1002/hep4.1037. eCollection 2017 Jul.
2
Systematic review: recurrent autoimmune liver diseases after liver transplantation.系统评价：肝移植后复发性自身免疫性肝病
Aliment Pharmacol Ther. 2017 Feb;45(4):485-500. doi: 10.1111/apt.13894. Epub 2016 Dec 12.
3
Long-Term Outcomes of Living-Donor Liver Transplantation for Primary Biliary Cirrhosis: A Japanese Multicenter Study.活体供肝肝移植治疗原发性胆汁性肝硬化的长期预后：一项日本多中心研究。
Am J Transplant. 2016 Apr;16(4):1248-57. doi: 10.1111/ajt.13583. Epub 2016 Jan 5.
4
Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence.原发性胆汁性肝硬化患者肝移植术后预防性应用熊去氧胆酸可降低疾病复发风险。
J Hepatol. 2015 Dec;63(6):1449-58. doi: 10.1016/j.jhep.2015.07.038. Epub 2015 Aug 14.
5
The genetics of complex cholestatic disorders.复杂胆汁淤积性疾病的遗传学。
Gastroenterology. 2013 Jun;144(7):1357-74. doi: 10.1053/j.gastro.2013.03.053. Epub 2013 Apr 10.
6
Calcineurin inhibitors and the IL12A locus influence risk of recurrent primary biliary cirrhosis after liver transplantation.钙调神经磷酸酶抑制剂和IL12A基因座影响肝移植后原发性胆汁性肝硬化复发的风险。
Am J Transplant. 2013 Apr;13(4):1110-1111. doi: 10.1111/ajt.12132. Epub 2013 Feb 22.
7
Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population.全基因组关联研究鉴定出 TNFSF15 和 POU2AF1 是日本人群原发性胆汁性胆管炎的易感基因位点。
Am J Hum Genet. 2012 Oct 5;91(4):721-8. doi: 10.1016/j.ajhg.2012.08.010. Epub 2012 Sep 20.
8
Cyclosporine A inhibits in vitro replication of betaretrovirus associated with primary biliary cirrhosis.环孢素 A 抑制与原发性胆汁性肝硬化相关的β逆转录病毒的体外复制。
Liver Int. 2010 Jul;30(6):871-7. doi: 10.1111/j.1478-3231.2010.02257.x. Epub 2010 May 14.
9
Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation.环孢素 A 可预防肝移植后原发性胆汁性肝硬化复发。
Am J Transplant. 2010 Apr;10(4):852-858. doi: 10.1111/j.1600-6143.2009.03006.x. Epub 2010 Feb 3.
10
Risk factors for recurrence of autoimmune hepatitis after liver transplantation.肝移植后自身免疫性肝炎复发的危险因素。
Liver Transpl. 2009 Oct;15(10):1254-61. doi: 10.1002/lt.21796.
Zotero 插件